docetaxel anhydrous has been researched along with ag-490 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (ag-490) | Trials (ag-490) | Recent Studies (post-2010) (ag-490) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 732 | 2 | 322 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | ag-490 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 1.9224 | |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | 3.38 | |
| large T antigen | Betapolyomavirus macacae | 14.61 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, Y; Hou, S; Kang, Z; Lin, Q | 1 |
1 other study(ies) available for docetaxel anhydrous and ag-490
| Article | Year |
|---|---|
Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Docetaxel; Extracellular Signal-Regulated MAP Kinases; Humans; Interleukin-6; Intracellular Signaling Peptides and Proteins; Multiple Myeloma; Phosphorylation; Phytotherapy; Serenoa; Signal Transduction; STAT3 Transcription Factor; Taxoids; Tyrphostins | 2009 |